After the great success of 2022, the appointment with the Congress of ESHRE (European Society of Human Reproduction and Embryology) – now in its 39th edition – is back. This year, from 25 to 28 June, it was the city of Copenhagen’s turn to host the Congress, which proved to be an important opportunity for doctors, companies and industry operators to exchange views and discuss the most relevant news in the field of fertility and reproductive medicine.
Therapeutic Areas
IBSA’s innovation at ESHRE
“EMBRACING GROWTH”, THE MAIN THEME FOR IBSA
Four days dedicated to innovation, with an attendance of over 13,000 participants from all over the world, interested in updates and scientific news concerning a rapidly growing and evolving area. The common thread for IBSA was “Embracing Growth”, a concept that refers to the desire to always be open to change, in order to accept and address any challenge and continue to improve, with courage and determination.
As usual, also this year IBSA organised a scientific symposium entitled Targeting the Endometrium, which promoted an exchange of views and a debate on the root causes of endometrial origin that can affect the success of ART. Moderated by experts of the calibre of Dominique de Ziegler (France) and Peter Humaidan (Denmark), the symposium was attended by Paul Pirtea (France), Edgardo Somigliana (Italy) and Shari Mackens (Belgium) as speakers.
All these contents will enrich IBSA Educational Program, the continuing education platform that IBSA has created to offer industry specialists high-profile insights.
The Congress was also an opportunity to forge new relationships with specialists and industry experts: IBSA’s stand was a privileged meeting place to showcase the company’s research and innovation, constantly focused on the search for increasingly more advanced and “patient-friendly” therapeutic solutions.
